We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$207B
AUM Growth
+$20.6B
Cap. Flow
+$7.99B
Cap. Flow %
3.86%
Top 10 Hldgs %
26.62%
Holding
9,816
New
1,347
Increased
3,278
Reduced
3,435
Closed
1,488

Sector Composition

Rank Sector Weight
1 Consumer Staples 2.31%
2 Technology 1.26%
3 Financials 1.12%
4 Healthcare 1.04%
5 Consumer Discretionary 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAB icon
7951
Gabelli Equity Trust
GAB
$1.77B
$90K ﹤0.01%
+16,522
New +$91.1K
LRMR icon
7952
Larimar Therapeutics
LRMR
$433M
$90K ﹤0.01%
2,263
+493
+28% +$22.4K
IMGN
7953
DELISTED
Immunogen Inc
IMGN
$90K ﹤0.01%
+33,584
New +$97.7K
PCOM
7954
PUT
DELISTED
Points.com Inc. Common Shares
PCOM
$90K ﹤0.01%
+10,100
New +$87.4K
TTPH
7955
PUT
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$90K ﹤0.01%
1,175
-605
-34% -$48.5K
GNRT
7956
CALL
DELISTED
Gener8 Maritime, Inc.
GNRT
$90K ﹤0.01%
17,500
+5,700
+48% +$30.8K
CDI
7957
DELISTED
CDI Corp.
CDI
$90K ﹤0.01%
+15,910
New +$93.2K
IPCI
7958
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$89K ﹤0.01%
+4,203
New +$75.4K
YGE
7959
DELISTED
Yingli Green Energy Holding Comp
YGE
$89K ﹤0.01%
22,892
+12,825
+127% +$50.3K
ASC icon
7960
CALL
Ardmore Shipping
ASC
$694M
$88K ﹤0.01%
12,500
-12,500
-50% -$91.5K
CPRX
7961
DELISTED
Catalyst Pharmaceutical
CPRX
$88K ﹤0.01%
80,497
-31,813
-28% -$28.6K
LPCN icon
7962
CALL
Lipocine
LPCN
$17.7M
$88K ﹤0.01%
1,159
-5,253
-82% -$325K
SVVC
7963
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$88K ﹤0.01%
+11,377
New +$82.4K
CALA
7964
DELISTED
Calithera Biosciences, Inc
CALA
$88K ﹤0.01%
1,349
-6
-0.4% -$387
PGNX
7965
PUT
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$88K ﹤0.01%
13,900
-20,400
-59% -$123K
JNP
7966
CALL
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$88K ﹤0.01%
+15,900
New +$105K
NWBO
7967
PUT
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$88K ﹤0.01%
162,300
-41,300
-20% -$18.9K
LITS
7968
CALL
Lite Strategy Inc
LITS
$33.8M
$87K ﹤0.01%
2,460
-1,695
-41% -$57K
NTBL
7969
PUT
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$87K ﹤0.01%
+477
New +$71.6K
GEN
7970
CALL
DELISTED
Genesis Healthcare, Inc.
GEN
$87K ﹤0.01%
+32,700
New +$75.2K
PGNX
7971
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$87K ﹤0.01%
+13,678
New +$82.7K
SDLP
7972
CALL
DELISTED
SEADRILL PARTNERS LLC
SDLP
$87K ﹤0.01%
2,460
-7,620
-76% -$322K
OSUR icon
7973
PUT
OraSure Technologies
OSUR
$256M
$86K ﹤0.01%
10,800
-34,900
-76% -$259K
RDNT icon
7974
CALL
RadNet
RDNT
$6.02B
$86K ﹤0.01%
+11,600
New +$73.9K
TGTX icon
7975
TG Therapeutics
TGTX
$8.42B
$86K ﹤0.01%
11,131
-18,892
-63% -$122K

Similar funds

Jeff Yass's Q3 2016 Portfolio in Review

As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.

By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Apple, an estimated $762M trimmed.

  • Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
  • Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
  • Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
  • Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
  • Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
  • Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
  • Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.

Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.